30
J Gandhara Med Dent Sci
October - December 2026
How to cite this article
:
:
FREQUENCY OF POSITIVE BLOOD CULTURES AND PATHOGEN DISTRIBUTION AMONG
FEBRILE PATIENTS ADMITTED TO NORTHWEST GENERAL HOSPITAL, PESHAWAR
Gul Rukhsar
1
,
Wafa Khan
2
,
Zainab Kamal
2
,
Wiqar Ahmad
3
, Sanam Fida
1
, Medrar Ullah Khan
4
Rukhsar G, Khan W, Kamal Z, Ahmad
W, Fida S, Khan MU. Frequency of
Positive Blood Cultures and Pathogen
Distribution Among Febrile Patients
Admitted to Northwest General
Hospital, Peshawar. J Gandhara Med
Dent Sci. 2026;13(4):30-35.
Date of Submission:
12-02-2026
Date Revised:
15-09-2026
Date Acceptance:
16-09-2026
2
Medical Officer, Department of
GeneralMedicine, Northwest General
Hospital & Research Center, Peshawar
3
Assistant Professor, Department of
General Medicine, Northwest General
Hospital & Research Center, Peshawar
4
Senior Registrar, Department of General
Medicine, Northwest General Hospital
& Research Center, Peshawar
Correspondence
1
Gul Rukhsar, Post Graduate Resident,
Department of Medicine, Northwest
General Hospital & Research Center,
Peshawar
+92-333-9232951
gulrukhsar7@gmail.com
ABSTRACT
OBJECTIVES
To
determine
the
frequency
of
positive
blood
cultures,
describe
the
distribution of clinically significant pathogens, and compare selected clinical
outcomes according to blood-culture status among febrile adult inpatients at
Northwest General Hospital, Peshawar.
METHODOLOGY
This prospective observational cohort study enrolled 129 consecutive febrile
patients aged 18-90 years admitted to the Department of General Medicine
from
January
to
June
2025.
Two
blood-culture
sets
were
collected
using
aseptic
technique
and
processed
in
an
automated
culture
system.
Positive
bottles underwent Gram staining, subculture, and organism identification by
matrix-assisted laser desorption ionisation time-of-flight mass spectrometry.
Patients
were
followed
until
discharge
or
in-hospital
death.
Data
were
analysed using SPSS version 25, with appropriate non-parametric and exact
tests; p<0.05 was considered significant.
RESULTS
Blood cultures were positive in 50/129 patients (38.8%). Enterobacteriaceae
accounted for 48.0% of positive cultures, Gram-positive cocci for 40.0%, and
non-fermenting Gram-negative rods for 12.0%. Staphylococcus aureus was
the most frequent species (22.0%). Carbapenems (31.0%) and cephalosporins
(27.9%) were the most frequently prescribed antimicrobial classes. Culture-
positive patients were less often male (48.0% vs 70.9%; p=0.015), had lower
median
diastolic
blood
pressure
(70
vs
80
mmHg;
p=0.004),
and
longer
median
hospital
stay
(4
vs 3
days;
p=0.043).
Mortality
was
higher
among
culture-positive
patients
(20.0%
vs
10.1%),
although
not
statistically
significant(p=0.126).
CONCLUSION
Bloodstream infection was frequent among febrile inpatients, with substantial
Gram-negative
and
Gram-positive
pathogen
burdens.
The
findings
support
timely
blood-culture
sampling,
careful
interpretation,
and
strengthened
antimicrobial
stewardship.
Local
surveillance
of
pathogen
distribution
and
resistance
should
guide
empiric
therapy
and
institutional
antibiotic
prescribing
in
this
hospital
population.
KEYWORDS:
Fever,
Blood
Culture,
Bloodstream
Infection,
Bacteremia,
Antimicrobial
Stewardship,
Enterobacteriaceae,
Mortality
INTRODUCTION
Fever
is
a
common
occurrence
among
hospitalised
patients,
accounting
for
2
to
29%
of
all
hospital
admissions,
and
is
frequently
used
as
a
clinical
justification
for
blood
culture.
1
Blood
culture
is
the
current
established
method
for
diagnosing
suspected
cases
of
bacteremia.
When
bacteremia
is
suspected,
most
high-income
countries
regularly
obtain
blood
cultures (BC) from febrile patients (FP).
2
The reported
prevalence
of
positive
BC
among
hospitalised
FP
ranges from 5 to 15%.
3,4
However, due to insufficient
or lacking laboratory capacity, doctors can opt to treat
patients
with
antibiotics
empirically.
In
resource-
constrained settings, especially in South Asia, BC are a
rapidly
growing
resource
that
can
inform
appropriate
treatment
and
encourage
antimicrobial
stewardship.
5,6
Given
the
World
Health
Organisation's
global
action
plan to combat antimicrobial resistance (AMR) and the
knowledge
of
how
AMR
impacts
the
attainment
of
Sustainable Development Goals, a better understanding
of
the
relationship
between
prescribed
antimicrobials,
blood
culture
use,
and
clinician
decision-making
can
help
direct
interventions
to
address
AMR.
7,8
Clinical
decisions,
such
as
choosing
the
right
antibiotic
if
necessary, can be guided by antimicrobial susceptibility
information obtained from BC. 2 BC were underutilised
among
FP
in
low-
and
middle-income
countries
(LMICs)
and
among
patients
who
were
ultimately
found to be bacteremic, according to an earlier study.
9
ORIGINAL ARTICLE
http://doi.org/10.37762/jgmds.13-4.867
31
J Gandhara Med Dent Sci
October - December 2026
BC for febrile cases when bacteremia is suspected may
not be ordered in many LMICs for a number of reasons,
such
as
the
assay's
low
sensitivity,
high
cost,
and the
lengthy
time
it
takes
to
obtain
results.
These
factors
may deter clinicians from ordering cultures in settings
like outpatient departments,
where
many patients
may
not
return
or
be
reachable
for
follow-up.
10
False
positive BC are linked to inappropriate antibiotic
use,
greater downstream testing, higher healthcare costs, and
longer
hospital
stays.
One
investigation
on
BC
of
febrile
patients
found
that
3.1%
of
the
BC
were
true
positive,
with
an
8.5%
diagnostic
yield.
The
most
frequently
isolated
pathogens
were
Staphylococcus
aureus
(22.0%),
Enterobacterales
(17.8%),
coagulase-
negative
Staphylococcus
spp.
(16.3%),
enterococci
(10.2%),
and
Candida
spp(7.0%).
1
This
study
aims
to
evaluate the diagnostic yield of BC among FP admitted
to
Northwest
General
Hospital.
While
blood-culturing
practices
vary
across
clinical
roles
and
experience
levels,
the
non-clinical
factors
influencing
culture
decisions remain underexplored. Given the importance
of BC in identifying pathogens and guiding appropriate
treatment,
this
research
seeks
to
determine
the
frequency of positive cultures and identify the isolated
pathogens.
The
findings
will
support
evidence-based
practices,
improve
patient
outcomes,
and
enhance
antibiotic stewardship and resource utilisation.
METHODOLOGY
This
prospective
observational
cohort
study
was
conducted
in
the
Department
of
General
Medicine,
Northwest
General
Hospital
&
Research
Centre,
Peshawar,
from
January
to
June
2025.
Consecutive
patients meeting the eligibility criteria were enrolled at
hospital admission and followed until discharge or in-
hospital
death.
The
study
was
conducted
after
institutional
ethical
clearance,
and
written
informed
consent
was
obtained
from
all
participants
before
enrollment.
Confidentiality
was
maintained
through
coded
study
records.
The
sample
size
was
calculated
using an anticipated blood-culture positivity of 3.1%, a
95% confidence level, and an absolute precision of 3%,
yielding
a
target
close
to
the
final
enrollment
of
129
patients.
Adults
of
either
sex
aged
18-90
years
with
documented fever at admission were eligible. Fever was
defined as an oral temperature of at least 38.0°C or a
rectal temperature of at least 38.3°C. Patients who had
received
systemic
antibiotics
within
the
preceding
48
hours,
patients
with
major
immunocompromising
conditions such as HIV infection, chemotherapy, organ
transplantation
or
neutropenia,
and
patients
with
localised
infections
for
which
blood
culture
was
not
routinely indicated
were excluded. Baseline data
were
recorded on a structured proforma. They included age,
sex,
body
mass
index,
residence,
educational
attainment, occupation, socioeconomic status, comorbid
conditions,
admission
temperature,
heart
rate,
respiratory
rate,
systolic
and
diastolic
blood
pressure,
duration
of
febrile
illness,
presenting
symptoms,
and
hospital
length
of
stay.
Hospital
outcome
was
categorised as discharge after clinical improvement or
in-hospital
death.
Because
outcome
status
was
determined from the index admission record, complete
in-hospital outcome data were available for all enrolled
participants. Blood cultures were obtained at enrollment
and, when clinically feasible, before the first in-hospital
dose
of
antimicrobial
therapy.
Trained
nursing
staff
performed
venipuncture
after
chlorhexidine
skin
antisepsis.
Two
culture
sets
were
collected
from
separate
venipuncture
sites,
with
each
set
containing
one aerobic and one anaerobic bottle. Approximately 8-
10
mL
of
blood
was
inoculated
into
each
bottle,
providing
an
intended
total
culture
volume
of
approximately 32-40 mL per patient. The two sets were
collected
approximately
20-30
minutes
apart
and
transported
promptly
to
the
microbiology
laboratory.
Blood-culture
bottles
were
incubated
in
an
automated
blood-culture
system
and
monitored
for
microbial
growth for
up to five days. Bottles flagged as positive
underwent
Gram
staining
and
subculture.
Organism
identification was performed using matrix-assisted laser
desorption/ionisation
time-of-flight
mass
spectrometry
(MALDI-TOF
MS).
Isolates
were
interpreted
as
clinically significant bloodstream infection or probable
contamination
according
to
organism
identity,
the
number of positive bottles or sets, repeat cultures when
available,
and
the
clinical
picture.
Coagulase-negative
staphylococci,
Corynebacterium
species,
Bacillus
species other than B. anthracis, and other typical skin
flora
were
considered
probable
contaminants
when
isolated from only one bottle or set without supporting
clinical
or
microbiological
evidence.
A
clinically
relevant
pathogen,
repeated
isolation
of
the
same
organism,
or
concordant
microbiological
and
clinical
findings
supported
classification
as
true
bloodstream
infection.
Polymicrobial
cultures
were
counted
as
one
culture-positive
episode
while
each
clinically
significant
organism
was
recorded
for
pathogen
distribution.
Antimicrobial
prescriptions
during
the
admission
were
grouped
by
antibiotic
class.
Because
individual patients could receive more than one agent,
antimicrobial percentages were not mutually exclusive
and therefore did not sum to 100%. The study did not
have sufficiently detailed time-stamped prescribing data
to separate empiric treatment from subsequent culture-
directed
therapy
reliably;
accordingly,
antibiotic
use
was
described
rather
than
interpreted
as
a
measure
of
appropriateness. Data
were analysed using IBM SPSS
Statistics
version
25.
All
tests
were
two-sided,
and
p<0.05 was considered statistically significant.
Frequency of Positive Blood Cultures and Pathogen Distribution
32
J Gandhara Med Dent Sci
October - December 2026
RESULTS
A
total
of
129
febrile
inpatients
were
included.
The
median age was 57 years (IQR 32-70), and 80 (62.0%)
participants
were
male.
The
median
body
mass
index
was 24.6 kg/m² (IQR 21.8-27.1). Diabetes mellitus was
documented in 68 (52.7%) patients and hypertension in
57
(44.2%).
At
presentation,
median
temperature
was
100.5°F
(IQR
100-101),
median
heart
rate
was
94
beats/min,
and
median
systolic
and
diastolic
blood
pressures were 120 and 76 mmHg. Length of hospital
stay (days, median (IQR): 3 (2-6). Regarding antibiotic
prescriptions,
carbapenems
were
the
most
frequently
prescribed antimicrobial class (40, 31.0%), followed by
cephalosporins
(36,
27.9%)
and
fluoroquinolones
(20,
15.5%).
Penicillins
and
no
antibiotic
were
each
prescribed to 19 (14.7%) patients, while glycylcyclines
and
macrolides
were
prescribed
to
11
(8.5%)
patients
each.
Other
prescribed
antimicrobial
classes
included
glycopeptides
(9,
7.0%),
lipopeptides
(8,
6.2%),
peptides
(8,
6.2%),
oxazolidinones
(6,
4.7%),
and
aminoglycosides (2, 1.6%). Patients could receive more
than
one
antimicrobial
agent.
Among
the
50
patients
with positive blood cultures, 10 (20.0%) died, while 40
(80.0%)
improved
and
were
discharged
(Table
4).
In
comparison,
when
the
entire
cohort
of
129
febrile
patients
was
considered,
18
(14.0%)
died,
and
111
(86.0%)
improved
and
were
discharged.
Of
the
79
patients with no growth/not identified, 8 (10.1%) died,
and
71
(89.9%)
improved
and
were
discharged.
The
duration of hospital stay ranged from 0 to 15 days, with
a mean duration of 5.23 ± 7.75 days and a median of 4
days.
Table 1: Baseline Characteristics of the Study Participants(n=129)
Variable
n (%age)
Gender
Male
80 (62.0)
Female
49 (38.0)
Socioeconomic status
Lower-middle
55 (42.6)
Upper-middle
59 (45.7)
High
15 (11.6)
Comorbid
Diabetes mellitus
68 (52.7)
Hypertension
57 (44.2)
Typhoid
12 (9.3)
Figure 1:
Presenting Symptoms of Patients
Table
2:
Frequency
of
Positive
Blood
Cultures,
Microbial
Isolates, and Antibiotics Prescribed
Variable
n (%age)
Blood culture status
Positive blood culture
50 (38.8)
No growth/not identified
79 (61.2)
Microbial isolates
among entire cohort
(n=129)
Non-fermenting Gram-
negative rods
6 (4.7)
Gram-positive cocci
20 (15.5)
Enterobacteriaceae
24 (18.6)
Microbial isolates
among culture-
positive patients
(n=50)
Non-fermenting Gram-
negative rods
6 (12.0)
Gram-positive cocci
20 (40.0)
Enterobacteriaceae
24 (48.0)
Note:
Percentages
for
microbial
isolates
in
the
first
section use
the
entire study cohort (n=129) as the denominator, whereas percentages
under "microbial isolates among culture-positive patients" use n=50
as the denominator.
Table
3:
Species-Level
Distribution
of
Microorganisms
Isolated
from Positive Blood Cultures
Organism identified
N
% of positive
cultures (n=50)
% of total
sample (n=129)
Staphylococcus aureus
11
22
8.5
Staphylococcus epidermidis
7
14
5.4
Escherichia coli
6
12
4.7
Enterobacter spp.
7
14
5.4
Providencia spp.
6
12
4.7
Salmonella typhi
4
8
3.1
Acinetobacter spp.
2
4
1.6
Pseudomonas aeruginosa
1
2
0.8
Pseudomonas spp.
1
2
0.8
Klebsiella spp.
1
2
0.8
Enterococcus spp.
2
4
1.6
Pantoea spp.
2
4
1.6
Table 4: Association Between Blood Culture Isolate and Hospital
Outcome Among Culture-Positive Patients
Blood
culture
isolate
Mortli
ty
Improved/
discharged
Total
RR (95
% CI)
p-value
n (%age)
Non-
fermenting
Gram-
negative rods
2
(33.3)
4
(66.7)
6
(100.
0)
1.83
(0.50
–
6.68)
0.116
Gram-
positive
cocci
6
(30.0)
14
(70.0)
20(100
.0)
2.25(0.73
– 6.98)
Enterobacteri
aceae
2
(8.3)
22
(91.7)
24(100
.0)
0.27(0.06
– 1.15)
Total
10
(20.0)
40
(80.0)
50(100
.0)
--
Note: Mortality (%) is calculated within each organism category. RR
compares the mortality risk for each organism category with all other
culture-positive
organism
categories
combined.
Overall
comparison
was performed using the Fisher–Freeman–Halton exact test.
Frequency of Positive Blood Cultures and Pathogen Distribution
33
J Gandhara Med Dent Sci
October - December 2026
Table
5:
Comparison
of
Demographic,
Clinical
Characteristics,
Comorbidities, and Outcomes According to Blood-Culture Status
Variable
Culture-posi
tive (n=50)
Culture-nega
tive (n=79)
p-value
Age, years, median (IQR)
57 (33.3)
56 (39.0)
0.494
Male sex, n (%)
24 (48.0)
56 (70.9)
0.015
Temperature, °F, median
(IQR)
101.0 (1.0)
100.0 (1.0)
0.309
Heart rate, beats/min,
median (IQR)
99.5 (40.0)
93.0 (15.5)
0.111
Systolic BP, mmHg,
median (IQR)
120 (30.0)
120 (18.0)
0.102
Diastolic BP, mmHg,
median (IQR)
70 (23.8)
80 (11.0)
0.004
Diabetes mellitus, n (%)
23 (46.0)
45 (57.7)
0.209
Hypertension, n (%)
22 (44.0)
35 (44.3)
1.000
Hospital stay length,
days, median (IQR)
4 (6.5)
3 (3.0)
0.043
Mortality, n (%)
10 (20.0)
8 (10.1)
0.126
Note: Continuous variables were compared using the Mann–Whitney
U test. Categorical variables were compared using Fisher's exact test.
DISCUSSION
In this study, the frequency of positive BC among FP
was 38.8%, which exceeds the positivity rates reported
in the literature. A study conducted in Nepal reports a
blood
culture
positivity
rate
among
FP
from
5%
to
28.5%
in
elderly
patients
with
other
studies
reporting
rates of 12.77% in Bangladesh 24.2% in Ethiopia
and
24.44%
in
pediatric
febrile
neutropenic
patients
in
Bali.
11,12,13,14
A
study
at
Khyber
Teaching
Hospital,
Peshawar, reported a lower positivity rate of 9% among
patients
with
non-focal
pyrexia.
15
The
blood-culture
positivity
rate
in
our
study
was
38.8%,
which
was
higher than that reported in several comparable studies.
This
relatively
high
positivity
rate
may
reflect
differences in patient selection, disease severity, blood-
volume collection,
microbiological
methods, and local
epidemiology.
Because
blood-culture
contamination
can
also
influence
reported
positivity
rates,
potential
contaminants were assessed using microbiological and
clinical criteria. Therefore, the observed positivity rate
should be interpreted in the context of the study setting
and
culture
interpretation
procedures.
The
predominance of Gram-negative organisms, particularly
Enterobacteriaceae
(18.6%),
in
our
study
aligns
with
global
findings.
Different
studies
similarly
reported
Gram-negative
rods,
especially
Escherichia
coli
,
Klebsiella
spp.
,
and
Pseudomonas
spp.,
as
the
most
frequent
pathogens.
14,16
This
consistent
predominance
emphasises
the
clinical
importance
of
Gram-negative
bacteremia,
especially
considering
its
association
with
higher
mortality
in
neutropenic
and
critically
ill
patients.
17,18
Our
findings
also
showed
a
substantial
proportion
of
Gram-positive
cocci
(15.5%),
including
likely
Staphylococcus
aureus
or
coagulase-negative
Staphylococci
,
paralleling
results
from
Ethiopian
and
Bangladeshi studies.
19
In terms of the use of antibiotics,
the most commonly prescribed class was carbapenems
(31%),
cephalosporins
(27.9%),
and
fluoroquinolones
(15.5).
This
prescription
trend
indicates
an
anchoring
towards
a
general-purpose
empiric
treatment,
presumably due to the severity of the clinical condition
and
apprehension
of
resistant
pathogens.
But
these
trends
are
concerning
with
regard
to
global
antimicrobial resistance (AMR). Examples in literature:
In
the
literature,
79
per
cent
of
antibiotics
used
pre-
hospital were in the WHO "Watch" category, and this is
alarming
due
to
the
inappropriate
use
of
empiric
antibiotics.
20.
Among
patients
with
positive
blood
cultures,
the
mortality
rate
was
20.0%
(10/50).
Organism-specific
mortality
was
highest
among
patients
with
non-fermenting
Gram-negative
rods
(33.3%, 2/6), followed by Gram-positive cocci (30.0%,
6/20)
and
Enterobacteriaceae
(8.3%,
2/24).
Although
mortality was numerically higher among patients with
non-fermenting Gram-negative rods and Gram-positive
cocci,
the
overall
association
between
organism
category
and
hospital
outcome
was
not
statistically
significant on exact testing (p = 0.116). Therefore, these
findings should be interpreted as descriptive rather than
evidence of a statistically significant organism-specific
mortality
difference.
Our
observation
of
numerically
higher
mortality
among
patients
with
Gram-positive
cocci
should
be
interpreted
cautiously
because
the
difference
was
not
statistically
significant
and
the
number
of
patients
in
the
individual
organism
categories
was
small.
Previous
studies
have
reported
differences
in
mortality
according
to
bloodstream
pathogen
characteristics.
21,22,23
However,
direct
comparison with our findings is limited by differences
in
patient
populations,
clinical
severity,
and
study
design.
LIMITATIONS
This
was
a
single-centre
study
with
a
relatively small
sample size, which limits generalizability and statistical
precision. Patients who had received antibiotics within
the
preceding
48
hours
and
several
immunocompromised
populations
were
excluded;
consequently, the findings should not be extrapolated to
all
febrile
medical
inpatients.
Detailed
antimicrobial
susceptibility
data,
infection
source,
severity
scores,
time
to
positivity,
and
time-stamped
antimicrobial
changes
were
not
available
for
complete
analysis.
Although contamination was assessed using clinical and
microbiological
criteria,
some
isolates
such
as
coagulase-negative
staphylococci
remain
difficult
to
classify
without
complete
device
and
repeat-culture
information. The study measured in-hospital outcomes
only
and
did
not
include
post-discharge
mortality
or
readmission.
Multivariable
modelling
was
not
Frequency of Positive Blood Cultures and Pathogen Distribution
34
J Gandhara Med Dent Sci
October - December 2026
undertaken,
so
observed
group
differences
may
be
influenced
by
unmeasured
confounding.
Future
multicentre
studies
should
integrate
antimicrobial
susceptibility,
antibiotic
timing,
stewardship
interventions, source of infection, severity adjustment,
and longer follow-up.
CONCLUSIONS
Positive
blood
cultures
were
common
among
febrile
inpatients
at
Northwest
General
Hospital,
with
Enterobacteriaceae and Gram-positive cocci accounting
for most clinically significant isolates.
Culture-positive
patients
had
longer
hospital
stays
and
numerically
higher mortality, although the mortality difference was
not
statistically
significant.
Frequent
use
of
carbapenems and cephalosporins reinforces the need to
connect
high-quality
blood-culture
practice
with
local
resistance
surveillance
and
antimicrobial-stewardship
programmes.
CONFLICT OF INTEREST:
None
FUNDING SOURCES:
None
REFERENCES
1.
Foong
KS,
Munigala
S,
Kern-Allely
S,
Warren
DK.
Blood
culture
utilisation
practices
among
febrile
and/or
hypothermic
inpatients.
BMC
Infect
Dis.
2022;22(1):779.
doi:10.1186/s12879-022-07748-x. PMID: 36217111.
2.
Ombelet S, Ronat JB, Walsh T, Yansouni CP, Cox J, Vlieghe E,
et
al.
Clinical
bacteriology
in
low-resource
settings:
today's
solutions.
Lancet
Infect
Dis.
2018;18(8).
doi:10.1016/S1473-
3099(18)30093-8. PMID: 29519767.
3.
Ingle
DJ,
Levine
MM,
Kotloff
KL,
Holt
KE,
Robins-Browne
RM.
Dynamics
of
antimicrobial
resistance
in
intestinal
Escherichia coli from children in community settings in South
Asia
and
sub-Saharan
Africa.
Nat
Microbiol.
2018;3(9):1063-
1073. doi:10.1038/s41564-018-0217-4. PMID: 30127495.
4.
Linsenmeyer
K,
Gupta
K,
Strymish
JM,
Dhanani
M,
Brecher
SM, Breu AC. Culture if spikes? Indications and yield of blood
cultures
in
hospitalised
medical
patients.
J
Hosp
Med.
2016;11(5):336-340. doi:10.1002/jhm.2541. PMID: 26762577.
5.
Lamy B, Dargère S, Arendrup MC, Parienti JJ, Tattevin P. How
to
optimise
the
use
of
blood
cultures
for
the
diagnosis
of
bloodstream
infections?
A
state-of-the-art.
Front
Microbiol.
2016;7:697. doi:10.3389/fmicb.2016.00697. PMID: 27242721.
6.
Swaminathan S, Prasad J, Dhariwal AC, Guleria R, Misra MC,
Malhotra
R,
et
al.
Strengthening
infection
prevention
and
control
and
systematic
surveillance
of
healthcare-associated
infections
in
India.
BMJ.
2017;358.
doi:10.1136/bmj.j3768.
PMID: 28874366.
7.
World Health Organization. Global action plan on antimicrobial
resistance.
Geneva:
World
Health
Organization;
2015.
PMID:
not available.
8.
Jasovsky
D,
Littmann
J,
Zorzet
A,
Cars
O.
Antimicrobial
resistance—a threat to the world's sustainable development. Ups
J
Med
Sci.
2016;121(3):159-164.
doi:10.1080/03009734.2016.1195900. PMID: 27416324.
9.
Teerawattanasook N, Tauran PM, Teparrukkul P, Wuthiekanun
V, Dance DAB, Arif M, et al. Capacity and utilisation of blood
culture in two referral hospitals in Indonesia and Thailand. Am J
Trop
Med
Hyg.
2017;97(4):1257-1261.
doi:10.4269/ajtmh.17-
0193. PMID: 28722626.
10.
Mogasale V, Ramani E, Mogasale VV, Park J. What proportion
of
Salmonella
Typhi
cases
are
detected
by
blood
culture?
A
systematic
literature
review.
Ann
Clin
Microbiol
Antimicrob.
2016;15(1):32.
doi:10.1186/s12941-016-0147-z.
PMID:
27188991.
11.
Sakurai T, Aiba M, Takahashi M, Sakamoto N, Yang KS, Tsuda
H, et al. Blood culture results in elderly febrile patients. Nihon
Ronen
Igakkai
Zasshi.
2015;52(4):367-373.
doi:10.3143/geriatrics.52.367. PMID: 26700776.
12.
Iqbal H, Mahboob N, Ahmed M, Mamun KZ, Rahim A, Azad
KA.
Bacteriological
profile
and
antimicrobial
susceptibility
patterns
of
blood
culture
isolates
among
febrile
patients
in
a
tertiary
care
hospital,
Bangladesh.
J
Dhaka
Med
Coll.
2018;27(2):114-122. doi:10.3329/jdmc.v27i2.45820.
13.
Ali
J,
Kebede
Y.
Frequency
of
isolation
and
antimicrobial
susceptibility
pattern
of
bacterial
isolates
from
blood
culture,
Gondar
University
Teaching
Hospital,
Northwest
Ethiopia.
Ethiop Med J. 2008;46(2):155-161. PMID: 21309205.
14.
Clearesta
KE,
Gustawan
IW,
Ariawati
K,
Fatmawati
NND,
Utama
MGDL,
Widnyana
AANKP,
et
al.
Microbial
blood
culture patterns and antibiotic susceptibility in pediatric febrile
neutropenia
at
Sanglah
General
Hospital
Bali.
Bali
Med
J.
2022;11(2):962-969. doi:10.15562/bmj.v11i2.3436.
15.
Badshah
A,
Naseer
A,
Ullah
I,
Ishaq
M.
Diagnostic
yield
of
blood cultures among patients admitted with non-focal pyrexias.
J
Gandhara
Med
Dent
Sci.
2024;11(1):26-29.
doi:10.37762/jgmds.11-1.486. PMID: not available.
16.
Sengar M, Kelkar R, Jain H, Biswas S, Pawaskar P, Karpe A.
Frequency
of
bacterial
isolates
and
pattern
of
antimicrobial
resistance
in
patients
with
hematological
malignancies:
a
snapshot
from
a
tertiary
cancer
center.
Indian
J
Cancer.
2014;51(4):456-458.
doi:10.4103/0019-509X.175387.
PMID:
26842160.
17.
Osmani AH, Jabbar AA, Gangwani MK, Hassan B. Outcomes
of high-risk patients with febrile neutropenia at a tertiary care
center.
Asian
Pac
J
Cancer
Prev.
2017;18(10):2741-2745.
doi:10.22034/APJCP.2017.18.10.2741. PMID: 29072402.
18.
Marghoob
B,
Khosravi-Khezri
M.
The
relationship
between
positive
cultures
with
multidrug-resistant
microorganisms
and
mortality
in
a
general
intensive
care
unit.
Avicenna
J
Clin
Microbiol Infect. 2022;9(2):70-76. doi:10.34172/ajcmi.2022.11.
19.
Wasihun
AG,
Wlekidan
LN,
Gebremariam
SA,
Dejene
TA,
Welderufael
AL,
Haile
TD,
et
al.
Bacteriological
profile
and
antimicrobial
susceptibility
patterns
of
blood
culture
isolates
among febrile patients in Mekelle Hospital, Northern Ethiopia.
Springerplus.
2015;4:314.
doi:10.1186/s40064-015-1056-x.
PMID: 26155453.
20.
Chowdhury
F,
Shuvo
TA,
Palit
A,
Rahman
MZ,
Ghosh
RK,
Angra
P,
et
al.
Antibiotic
use
before
and
after
hospital
admission among hospitalised patients with acute febrile illness
in
Bangladesh
[abstract].
Open
Forum
Infect
Dis.
2023;10(Suppl 2).1863. doi:10.1093/ofid/ofad500.1863. PMID:
not available.
21.
Agarwal
K,
Kapil
J,
Kumari
PHP.
Study
of
bacterial
agents
causing
febrile
illnesses
in
children
between
1
month
to
12
years
of
age
in
a
tertiary
care
hospital
in
Sikkim.
Int
J
Curr
Microbiol
Appl
Sci.
2020;9(10):1310-1323.
doi:10.20546/ijcmas.2020.910.158.
22.
Søgaard
M,
Nørgaard
M,
Pedersen
L,
Sørensen
HT,
Schønheyder
HC.
Blood
culture
status
and
mortality
among
patients
with
suspected
community-acquired
bacteremia:
a
population-based
cohort
study.
BMC
Infect
Dis.
2011;11:139.
doi:10.1186/1471-2334-11-139. PMID: 21599971.
Frequency of Positive Blood Cultures and Pathogen Distribution
35
J Gandhara Med Dent Sci
October - December 2026
LICENSE:
JGMDS publishes its articles under a Creative Commons Attribution Non-Commercial Share-Alike license (
CC-BY-NC-SA 4.0
).
COPYRIGHTS:
Authors retain the rights without any restrictions to freely download, print, share and disseminate the article for any lawful purpose.
It includes scholarlynetworks such as Research Gate, Google Scholar, LinkedIn, Academia.edu, Twitter, and other academic or professional networking sites.
23.
Bonadia
N,
Della
Polla
DA,
Murri
R,
D'Inzeo
T,
Fiori
B,
Carnicelli A, et al. Comparative mortality analysis in febrile and
afebrile
emergency
department
patients
with
positive
blood
cultures: a retrospective study. Microbiol Res. 2024;15(3):1073-
1082. doi:10.3390/microbiolres15030070.
Gul
Rukhsar
-
Concept
&
Design;
Data
Acquisition;
Drafting Manuscript; Final Approval
Wafa Khan
-
Concept & Design; Data Acquisition; Data
Analysis/Interpretation;
Drafting
Manuscript;
Critical
Revision; Supervision; Final Approval
Zainab
Kamal
-
Concept
&
Design;
Data
Acquisition;
Data
Analysis/Interpretation;
Drafting
Manuscript;
Supervision;
Final Approval
Wiqar
Ahmad
-
Concept
&
Design;
Data
Acquisition;
Drafting Manuscript; Critical Revision; Final Approval
Sanam Fida
-
Concept & Design; Data Acquisition; Data
Analysis/Interpretation;
Drafting
Manuscript;
Final
Approval
Medrar
Ullah
Khan
-
Concept
&
Design;
Data
Acquisition;
Drafting
Manuscript;
Final
Approval
AUTHORS CONTRIBUTION
The authors accept responsibility for all aspects of the work
and will ensure that any concerns regarding the accuracy or
integrity of any part are properly investigated and resolved.
Frequency of Positive Blood Cultures and Pathogen Distribution